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Hepatoma cells derived from the Reuber H35 rat hepatoma express cytochrome P450 enzymes oftwo major families: 
polycyclic aromatic hydrocarbon-inducible forms are found in both differentiated and dedifferentiated c lls while phen- 
obarbital (PB)-inducible forms are found only in differentiated cells. We report here that (i) benzanthracene a dPB indu- 
ce P450 c mRNA in differentiated and dedifferentiated c lls and (ii) dexamethasone a dPB induce P450 b/e and/or P450 
PBI mRNAs in differentiated cells but not in dedifferentiated c lls. 
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1. INTRODUCTION 
Cytochromes P450 belong to a superfamily of 
enzymes involved in the metabolism of en- 
dogenous substrates such as fatty acids and 
steroids, and in the detoxification as well as in the 
activation of xenobiotics [1]. Several cytochrome 
P450 families were initially characterized by their 
response to inducer compounds such as PB, PAH, 
glucocorticoids and ethanol [1]. Most cytochrome 
P450 genes are expressed in the liver of inducer- 
treated animals. In mice, the results from both in 
vivo and in vitro studies suggested the existence of 
a specific receptor, encoded by the Ah locus, and 
mediating the induction of the P450 P1 gene 
(equivalent to rat P450 c) by PAH [2]. There is on- 
ly little information concerning the induction of 
PB-inducible cytochrome P450 genes by PB [3] 
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due to an acute lack of mutant animal strains and 
PB-responsive cell lines. 
Cells derived from the Reuber H35 rat hepatoma 
express cytochrome P450 enzyme activities [4]. 
Aryl hydrocarbon hydroxylase activity has been 
found in both differentiated and dedifferentiated 
rat hepatoma lines. Moreover, the differentiated 
cell lines are exceptional in exhibiting aldrin epox- 
idase activity, an indicator of PB-inducible 
cytochromes P450 [4,5]. They thus are likely to 
constitute a unique in vitro system to carry out 
genetic and biochemical studies on the regulation 
of expression of PB-inducible cytochrome P450. 
We show here that (i) BA (a typical PAH com- 
pound) and PB induce an increase in the amount 
of P450 c mRNA in both differentiated and dedif- 
ferentiated cells and (ii) DEX and PB induce an in- 
crease in the amount of P450 b/e and PBI mRNAs 
in differentiated cells but not in dedifferentiated 
cells. 
2. MATERIALS AND METHODS 
ACI male rats (from which the hepatoma cell lines were in- 
itially derived) were injected intraperitoneally once or every 
24 h for 3 days; following treatment, they were killed by cer- 
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Fig. 1. P450 c mRNA levels. (a) Comparison between liver and 
Fao cells treated by various inducers. (b) For the combination 
PB + BA, PB for 72 h, BA added for the last 24 h. B stands for 
basal level. 
vical dislocation after overnight starving. 3-MC (100 mg/kg 
body wt, in oil), PB (100 mg/kg body wt, in 50o70, v/v, 
ethanol/glycerol) and DEX (5 mg/kg body wt, in water) were 
diluted in normal saline. For cultures, the following conditions 
of inducer treatments have been determined as optimal, and 
unless stated otherwise include, BA (for 24 h) in DMSO, PB 
(72 h) and DEX (24 h) in phosphate buffered saline, added at 
a final concentration f 10 -6, 2 x 10 -3 and 10 -6 M, respective- 
ly. As controls, solvents alone were injected into the animals or 
added to cells. Cell lines and culture conditions have been 
described [6]. RNA preparation, Northern blotting, hybridiza- 
tion and washes are detailed in [7]. For each RNA gel, 10 or 
15/~g of total RNA were loaded per lane. cDNA probes, 
generously provided by A. Anderson and M. Adesnik, include: 
C6 [8], which corresponds to P450 c mRNA; R17 [9] to P450 
b/e; and pTF2 [10] to P450 PBI. The probes do not cross- 
hybridize to one another and reveal mRNAs of 3 kb (C6), 
2.1 kb (Rl7) and 1.9 kb (pTF2) long (not shown). The relative 
intensities of the hybridization signals were estimated by using 
a BioRad densitometer. 
3. RESULTS AND DISCUSSION 
Clonal hepatoma cell lines previously 
characterized for their P450 enzyme activities 
([4,5] and Wiebel, F.J., personal communication) 
were used. The differentiated cells (Fao, C2Rev7 
and H4II) express a whole set of hepatic functions 
including serum proteins (albumin, fibrinogen, 
al-antitrypsin) and enzymes (alcohol dehydro- 
genase, aminotransferases, fructose diphospha- 
tase, phosphoenolpyruvate carboxykinase). The 
dedifferentiated cells (P4, H5-6 and C2) fail to ex- 
press most or all of these functions [6]. To analyze 
the profile of induction of cytochromes P450, we 
compare the results obtained for rat liver and for 
the widely used differentiated Fao cell line; then, 
we present the results obtained for the other 
hepatoma lines. 
3.1. Expression of  the cytochrome P450 c gene 
As revealed with the C6 probe, the basal level of 
P450 c mRNA is very low in both liver and Fao 
cells (fig. la). A single injection of 3-MC to the rat, 
or exposure of Fao cells to BA, lead to comparable 
increases (20-30-fold) of P450 c mRNA,. PB in- 
duces a 3-5-fold increase of the mRNA in both rat 
liver and Fao cells. Since the amounts of P450 c 
mRNA, following 3-MC (or BA) and PB induc- 
tion, are comparable in liver and Fao cells, it is 
likely that the cultured ceils use the same 
mechanisms as hepatocytes for induced expression 
of the P450 c gene. 
Pretreatment of the ceils by PB before addition 
of BA results in a much larger increase (three times 
the effect of BA alone) of P450 c mRNA than ex- 
pected for an additive ffect (fig. 1). This synergism 
would result if, as has been found for rat liver 
[8,9], PB induces in Fao cells an increase in the in- 
tracellular concentration of receptor molecules for 
PAH compounds. 
As shown in fig.2, the inducibility of P450 c 
mRNA by BA and/or PB does not depend on the 
degree of differentiation of the hepatoma cell 
lines. BA and PB induce this mRNA in Fao and P4 
cells; BA but not PB is effective in H4II and H5-6 
C6 
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Fig.2. Expression and inducibility of the cytochrome P450 c gene (C6 probe) in three differentiated (left) and three dedifferentiated 
(right) cell lines. B, basal. 
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Fig.3. P450 b/e mRNA levels. Comparison between untreated 
or PB-treated liver and Fao cells. B, basal. 
cells. Neither BA nor PB is effective in C2Rev7 
and C2 cells. 
3.2. Expression of the cytochrome P450 b/e genes 
In liver, as revealed with the R17 probe, the 
P450 b/e genes are expressed at a very low basal 
level, but they are highly inducible by PB (50-fold) 
(fig.3). In contrast, in Fao cells, P450 b/e mRNA 
is 3-5-fold more abundant han in liver, but it is 
only slightly (2-fold) inducible by PB. 
The results presented in fig.4a show that PB in- 
duces P450 b/e mRNA in C2Rev7 cells but not in 
H4II cells. DEX increases the amount of P450 b/e 
mRNA in H4II cells but not in the PB-responsive 
Fao and C2Rev7 cells. Neither PB, nor DEX in- 
duces this mRNA in the dedifferentiated cell lines. 
3.3. Expression of the cytochrome P450 PB1 gene 
The level of P450 PB 1 mRNA in liver is higher 
than that of P450 b/e, but it undergoes only a 
3-fold increase upon PB induction (fig.5). DEX 
Fig.5. P450 PB1 mRNA levels. Comparison between liver (L) 
and Fao (F) cells treated by various inducers. B, basal. 
and 3-MC have no effect on the accumulation of 
P450 PB1 mRNA in liver. In Fao cells, P450 PB1 
mRNA is less abundant than in liver, but it 
undergoes a 14-fold increase upon PB induction. 
DEX also induces a large (10-fold) increase in the 
amount of P450 PB1 mRNA; BA is not effective. 
Exposure of Fao cells to a mixture of DEX and PB 
does not result in a further increase in P450 PB1 
mRNA (not shown). PB and DEX induce this 
mRNA in the differentiated C2Rev7 and H4II 
cells, but not in the dedifferentiated cells (fig.4b). 
These results how that the basal and PB and/or 
DEX-induced expression of P450 b/e and PB1 
cytochrome P450 genes is restricted to the differen- 
tiated cells. The expression of these genes may thus 
be considered as a differentiated trait of the rat 
hepatoma cells, as opposed to the ubiquitous ex- 
pression of the P450 c gene. The differences in the 
expression of the P450 b/e and PB1 genes, be- 
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Fig.4. Expression and inducibility, in three differentiated (left) and three dedifferentiated (right) cell lines, of (a) the cytochrome P450 
b/e genes (RI7 probe) and (b) the cytochrome P450 PBI gene (pTF2 probe). B, basal. 
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Table 1 
Factor of induction of P450 mRNAs in rat liver and hepatoma 
cells 
P450 c P450 b/e P450 PB1 
Liver MC 27 I a 1 
DEX I a I a 1 
PB 3 50 3 
Fao BA 20 l 1 
DEX I a < l 1 l 
PB 5 2.2 14 
H4II BA 85 ND b ND 
DEX ND 1.3 9 
PB l 1 3 
C2Rev7 BA _ c ND ND 
DEX - < 1 5.8 
PB - 1 .8  10  
H5-6 BA 40 - - 
DEX ND - - 
PB  1 - - 
P4 BA 60 - - 
DEX ND - - 
PB 5 - - 
C2 BA - - - 
DEX ND - - 
PB - - - 
a Data not shown 
b ND. not determined 
c - ,  not detectable 
tween rat  l iver and  the  d i f fe rent ia ted  hepatoma 
cells, might  be  due  to  cell heterogene i ty  e i ther  in 
the cu l tu red  cells or  in l iver. However ,  s ince these 
d i f fe rences  in response  to  PB  are on ly  quant i ta t ive ,  
d i f fe rent ia ted  rat  hepatoma cells const i tu te  a 
va luab le  in v i t ro  system to invest igate  the  induc-  
t ion  pathway o f  the  cytochromes  P450 b /e  and  
PB1 by  PB .  
As  summar ized  in tab le  1, each  o f  the  rat  
hepatoma cell l ines character i zed  here  presents  a 
d is t inct  pro f i le  o f  induced express ion  o f  the  
cytochrome P450 genes.  Fao  cells are  the  most  
respons ive ;  at  the  o ther  ext reme,  C2 cells are 
negat ive  by  all cr i ter ia .  The  ava i lab i l i ty  o f  such  a 
var ie ty  o f  cell l ines, e i ther  respons ive  or  not  to 
P450 inducers ,  permi ts  genet ic  and  molecu lar  
ana lyses  o f  fac tors  cont ro l l ing  the  express ion  o f  rat  
P450 genes.  
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